BioCryst Pharmaceuticals | BCRX - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Chugai Pharma JPY 411.08B 143.65B 2025-12
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
DBV Technologies USD 49.48M 60K 2025-09
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novavax USD 459.95M 30.08M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12